СÊóËɳÚËØ3(RLN3)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¿¹Ìǵ°°×¿¹Ìå(GP)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóºÚÉ«ËØÁöתÒƱíÃæ𤸽·Ö×Ó(MMSAM)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¿ÉÈÜÐÔËáÐÔÁ×Ëáø1(sACP1)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¿¹Éú³¤¼¤ËØ¿¹Ìå(GHAb)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóBcl-2Ïà¹ØËÀÍö´Ù½øÒò×Ó£¨BAD£©elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóºËÈÊÐγÉÇøÊÈÒøµ°°×(Ag-NORs)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóAXIN1(Axin1) elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¼¡ÈâË¿Çе°°×2£¨MC2£©elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóβÐÍͬԴºÐ2£¨CDX2£©elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¦Á¸¨¼¡¶¯µ°°×3(ACTN3)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóÏËÁ¬µ°°×¸»º¬ÁÁ°±Ëá¿çĤµ°°×2£¨FLRT2£©elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¹ÇÐÎ̬·¢Éúµ°°×ÊÜÌå2ÐÍ£¨Ë¿°±Ëá/ËÕ°±Ëἤø£©(BMPR2)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊ󿹺ËÌÇÌåRNP¿¹Ìå(Anti-RRNP)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó½»ÁªµÄIÐͽºÔ­ôÈ»ùÄ©¶ËëÄ£¨CCTCI£©elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóÄÚÂð·ÈëÄ-2(EM-2)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¿¹ÂÑÇåµ°°×IgE(Anti-OVA-IgE)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóÇ÷»¯ËØÑùÒò×ÓMARVEL¿çĤ½á¹¹Óò°üº¬6£¨CMTM6£©elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó°×ÈýÏ©E4(LTE4)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóÔçÆÚÉú³¤·´Ó¦Òò×Ó4(EGR4)elisa¼ì²âÊÔ¼ÁºÐ

ÐͺÅ: